These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31183936)

  • 1. Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogs.
    Gregory JM; Kraft G; Scott MF; Neal DW; Farmer B; Smith MS; Hastings JR; Madsen P; Kjeldsen TB; Hostrup S; Brand CL; Fledelius C; Nishimura E; Cherrington AD
    Diabetes Obes Metab; 2019 Oct; 21(10):2294-2304. PubMed ID: 31183936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog.
    Edgerton DS; Moore MC; Winnick JJ; Scott M; Farmer B; Naver H; Jeppesen CB; Madsen P; Kjeldsen TB; Nishimura E; Brand CL; Cherrington AD
    Diabetes; 2014 Nov; 63(11):3946-54. PubMed ID: 24947349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
    Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
    Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a selective rise in hepatic artery insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Igawa K; Chu CA; Balcom JH; Neal DW; Cherrington AD
    Am J Physiol; 1999 Apr; 276(4):E806-13. PubMed ID: 10198319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
    Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal hepatic glucose production is regulated by the portal vein insulin concentration.
    Sindelar DK; Chu CA; Venson P; Donahue EP; Neal DW; Cherrington AD
    Diabetes; 1998 Apr; 47(4):523-9. PubMed ID: 9568682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.
    Camacho RC; Pencek RR; Lacy DB; James FD; Donahue EP; Wasserman DH
    Diabetes; 2005 Feb; 54(2):373-82. PubMed ID: 15677495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
    Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
    Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
    Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior Glycemic Control With a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts.
    Moore MC; Kelley DE; Camacho RC; Zafian P; Ye T; Lin S; Kaarsholm NC; Nargund R; Kelly TM; Van Heek M; Previs SF; Moyes C; Smith MS; Farmer B; Williams P; Cherrington AD
    Diabetes; 2018 Jun; 67(6):1173-1181. PubMed ID: 29540491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans.
    Lewis GF; Carpentier A; Bilinski D; Giacca A; Vranic M
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1037-46. PubMed ID: 10084592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM.
    Canavan JP; Flecknell PA; New JP; Alberti KG; Home PD
    Diabetologia; 1997 Oct; 40(10):1125-34. PubMed ID: 9349592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
    Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
    Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes.
    Gregory JM; Kraft G; Scott MF; Neal DW; Farmer B; Smith MS; Hastings JR; Allen EJ; Donahue EP; Rivera N; Winnick JJ; Edgerton DS; Nishimura E; Fledelius C; Brand CL; Cherrington AD
    Diabetes; 2015 Oct; 64(10):3439-51. PubMed ID: 26085570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.
    Galassetti P; Shiota M; Zinker BA; Wasserman DH; Cherrington AD
    Am J Physiol; 1998 Jul; 275(1):E101-11. PubMed ID: 9688880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
    Rebrin K; Steil GM; Getty L; Bergman RN
    Diabetes; 1995 Sep; 44(9):1038-45. PubMed ID: 7657026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin.
    Camacho RC; Pencek RR; Lacy DB; James FD; Wasserman DH
    Diabetes; 2004 Feb; 53(2):285-93. PubMed ID: 14747277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis RM; Hartley CJ; Entman ML; Field JB
    Diabetes; 1984 Oct; 33(10):984-90. PubMed ID: 6383906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.